BROAD ARROW, A HAGERTY COMPANY, ESTABLISHES EXCLUSIVE NORTHEAST PRESENCE AS AUDRAIN SOLIDIFIES POSITION AS REGION'S PREMIER AUTOMOTIVE DESTINATION A snapshot of the 2025 Audrain Newport Concours, which will feature Broad Arrow as exclusive auction partner beginning in 2026. Credit - Francesca Dolnier / Courtesy of Audrain Newport Concours & Motor Week A snapshot of the 2025 Audrain Newport Concours, which will feature Broad Arrow as exclusive auction partner beginning in 2026. Credit - Francesca Dolni ...

公司财务与活动安排 - 公司将于2025年11月10日美股市场收盘后发布2025年第三季度财务业绩 [1] - 管理层将于2025年11月10日东部时间下午4:30举行网络直播和电话会议 [1] 公司业务与产品管线 - 公司是一家专注于开发针对罕见病的变革性细胞和基于外泌体疗法的生物技术公司 [2] - 公司的主要候选产品Deramiocel是一种同种异体心脏来源的细胞疗法 目前正处于治疗杜氏肌营养不良症的后期临床开发阶段 [2] - 临床前和临床数据表明Deramiocel具有强大的免疫调节和抗纤维化作用 有助于保留DMD患者的心肌和骨骼肌功能 [2] - 公司正利用其专有的StealthX™外泌体技术平台进行临床前开发 专注于疫苗学以及寡核苷酸、蛋白质和小分子疗法的靶向递送 [2] 商业合作与监管状态 - 公司已与日本新药株式会社就Deramiocel在美国和日本用于DMD的独家商业化和分销达成协议 该协议需经监管批准 [5] - Deramiocel和StealthX™疫苗均为研究性候选产品 尚未在任何适应症中获准商业使用 [5]

Order strengthens growing partnership to deploy long-duration energy storage across multiple marketsPITTSBURGH, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Eos Energy Enterprises, Inc. (NASDAQ: EOSE) ("Eos" or the “Company”), an American energy company and the leading innovator in designing, sourcing, manufacturing, and providing zinc-based battery energy storage systems (BESS) and Frontier Power Ltd. (“Frontier”), a leading UK-based energy developer, today announced a strategic 228 megawatt-hour (MWh) order to deplo ...

On 31 October 2025 the Annual General Meeting of Shareholders of AB Akola Group approved the consolidated and the Company’s Financial Statements, consolidated Management Report, the Independent Practitioners’ Limited Assurance Report on AB Akola Group consolidated Sustainability Report, and Independent Auditor's Report on the Company’s consolidated Financial Statements for the financial year ended 30 June 2025. Key financial indicators Consolidated revenues of the subsidiaries of AB Akola Group (the Group) ...

Faster initial remission and response, persistent benefit over six monthsSALT LAKE CITY, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced a post-hoc analysis of the Precision Medicine in Mental Health Care (PRIME) study showed that treatment informed by the GeneSight® test led to faster initial remission and response in patients with Major Depressive Disorder (MDD). Further, the post-hoc analysis showed ...

Correcting press release issued under same heading: Date in body text corrected to "November 6, 2025" as in headline. COPENHAGEN, Denmark, October 31, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will provide a business update and report its third quarter 2025 financial results on Thursday November 6, 2025, before opening of the Nasdaq CM. Evaxion’s Executive Management will host a conference call and webcast the ...

A Media Snippet accompanying this announcement is available by clicking on this link. ABU DHABI, United Arab Emirates, Oct. 31, 2025 (GLOBE NEWSWIRE) -- SEGG Media Corporation (Nasdaq: SEGG, LTRYW) (“SEGG Media” or “the Company”), today announced that two Racing Women drivers will compete this weekend in Round 1 of the 2025/26 Gulf Radical Cup at Yas Marina Circuit marking another milestone in the company’s expanding influence across global motorsport and women’s racing. The SEGG Media and Sports.com team ...

New York, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Linkers Industries Limited (Nasdaq: LNKS) (the “Company”), a manufacturer and a supplier of wire/cable harnesses with operation in Malaysia, today announced closing of the transaction with LPW Electronics Co., Ltd. On October 16, 2025, Linkers Asia Pacific Limited (“Linkers Asia”), a wholly owned subsidiary of Linkers Industries Limited (the “Company”) entered into a Share Sale and Purchase Agreement (“SPA”), with Mr. Man Tak Lau, the chairman of the board of dire ...

技术测试概述 - 公司启动Starlink Direct to Cell技术的全国测试第二阶段，测试范围覆盖除边境地区、交战区和临时被占领土外的乌克兰全境[1] - 该技术旨在为地面服务不可用的地区提供关键连接[1] - 测试已获得国家电子通信、无线电频谱和邮政服务监管委员会的许可，并将使用公司已获授权的频率进行[2] 技术应用场景与计划 - 该技术预计在长期停电、前线、新解放地区、人道主义排雷、紧急服务、山区及其他无移动网络覆盖的难以到达区域特别有用[3] - 公司计划让用户和商业客户参与测试，以在挑战性条件下确保不间断连接和业务韧性[3] - 测试将评估该技术在从紧急情况到日常使用的各种场景下的有效性[4] - 到2025年底，所有乌克兰人预计将开始测试这项技术[5] 技术能力与监管 - Starlink Direct to Cell技术使标准4G智能手机无需地面基站即可直接连接卫星[5] - 实施第一阶段，短信功能预计仅限户外、天空视野清晰的区域使用，且不向用户收取额外费用[5] - 未来阶段将引入语音通话和移动互联网，显著扩展服务能力[5] - 监管机构支持新技术的引入，但会确保测试不影响现有网络运行、不造成无线电干扰并完全符合所有技术要求[5] 公司业务与投资 - 公司是乌克兰领先的数字运营商，截至2025年6月30日，拥有约2240万移动用户和超过110万固网家庭互联网客户[6] - 公司提供4G、大数据、云解决方案、网络安全服务、数字电视等多种服务[6] - 公司与VEON计划在2023-2027年间投资10亿美元用于发展新的电信技术[6] - 公司在过去三年已拨款超过34亿乌克兰格里夫纳用于支持国防部队、用户和社会项目[6]

CHATSWORTH, Calif., Oct. 31, 2025 (GLOBE NEWSWIRE) -- XYRA Corp., a subsidiary of Cavitation Technologies, Inc. (OTCQB: CVAT), today announced a strategic partnership with Bitcoin Bancorp, Inc. (OTCQB: BCBC), a leading blockchain company and owner of key Bitcoin ATM patents. The collaboration combines XYRA’s AI-driven, quantum-secure payment infrastructure platform, currently in development, with Bitcoin Bancorp’s licensed ATM network and patented technologies to deliver next-generation crypto payment solut ...